ERBB2 and neoplasm: No statistically significant associations could be detected between SARIFA status and patients’ sex, age, tumour localization, tumour grade, presence of distant metastases, lymph node ratio, lymphatic or vascular invasion, status of resection lines, EBV, MSI, HER2 and MET status.